In 2022, a change to Section 174 of the tax code required businesses to capitalize and amortize domestic R&D costs over five years instead of deducting them immediately. For CPG brands that spend money on product development, formulation work, packaging innovation, and manufacturing process improvement, this meant taxable income was significantly higher in those years than it should have been under the prior rules. Many smaller brands were caught off guard and paid taxes they did not expect. The One Big Beautiful Bill Act reversed this entirely. Domestic R&D is fully deductible again starting with tax years beginning after December 31, 2024. And more importantly for businesses that already paid those extra taxes, there is a retroactive recovery path available right now.
For businesses with average annual gross receipts of $31 million or less over the prior three years, the OBBBA allows amended returns for 2022, 2023, and 2024 to apply the new immediate expensing rules retroactively. If your CPG brand spent $250,000 per year on qualifying domestic R&D during those three years and was forced to amortize instead of deduct, you have $600,000 in deferred deductions potentially sitting in those prior returns. At a 25% effective tax rate, that is up to $150,000 in taxes you overpaid that may be recoverable. That is not a rounding error. That is real cash.
Businesses above the $31 million threshold also have a path. You can elect to deduct the remaining unamortized balance from 2022 through 2024 either entirely on the first return after December 31, 2024, or spread over two years. That does not require amended returns. It is a catch-up deduction on your current return. Either way, the mechanics interact with your R&D tax credit calculation, so the optimal approach depends on your specific situation and requires a conversation with your CPA. But that conversation needs to happen now because the amended return window has a statute of limitations that will eventually close.
Bottom Line: If your brand spent money on domestic R&D from 2022 through 2024, you likely overpaid federal taxes under the forced amortization rules. The window to recover that money is open right now. Do not wait for the next annual planning meeting to start this conversation.